期刊文献+

抗TNF-α疗法治疗银屑病关节炎和银屑病 被引量:6

下载PDF
导出
摘要 PsA的病变关节和银屑病的病变皮肤上的TNF-α均增高,抑制TNF-α可导致PsA的病变关节和银屑病的病变皮肤中的多种促炎细胞因子(如IL-1、IL-6、IL-8、VEGF和血管紧张素Ⅱ)和多种活性细胞(如破骨细胞、角化细胞、T细胞、中性粒细胞、淋巴细胞、浆细胞和肥大细胞)的数量减少,从而使关节和皮肤的炎症减轻,进而令大多数患者的临床表现和生活质量明显改善。
作者 梁东风 黄烽
出处 《中国药物应用与监测》 CAS 2005年第3期39-42,共4页 Chinese Journal of Drug Application and Monitoring
  • 相关文献

参考文献16

  • 1张江林,黄烽,刘湘源.银屑病关节炎临床特点及与HLA-B27的相关性研究[J].中华风湿病学杂志,1999,3(2):87-89. 被引量:23
  • 2张江林,张振春,黄烽.以关节炎为首发表现的银屑病关节炎的临床特征[J].中华风湿病学杂志,2003,7(4):201-203. 被引量:7
  • 3[4]Moll J,Wright V.Psoriatic arthritis[J].Seminars Arthritis Rheum,1973,3:55.
  • 4[5]Mease P.TNF-o therapy in psoriatic arthritis and psoriasis:how and why does it work[J].Ann Rheum Dis,2004,63(7) :755.
  • 5[6]Genovese MC,Bathon JM,Martin RW,et al.Etanercept versus methotrexate in patients with early rheumatoid arthritis:2-year radiographic and clinical outcomes[J].Arthritis Rheum,2002,46:1443.
  • 6[7]Furst DE,Schiff MH,Fleischmann RM,et al. Adalimumab,a fully human anti-tumor necrosis factor-alpha monoclonal antibody, and concomitant standard anti-rheumatic therapy for the treatment of rheumatoid arthritis:results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)[J].J Rheumatol,2003,30: 2563.
  • 7[8]Mease PJ,Goffe BS,Metz J,et al. Etanercept in the treatment of psoriatic arthritis and psoriasis:a randomized trial[J].Lancet,2000,356: 385.
  • 8[9]Antoni C,Dechant C,Hanns-Martin Lorenz PD,et al. Open-label study of infliximab treatment for psoriatic arthritis:clinical and magnetic resonance imaging measurements of reduction of inflammation[J].Arthritis Rheum, 2002,47:506.
  • 9[10]Davis JC Jr,Van Der Heijde D,Braun J,et al. Recombinant human tumor necrosis factor receptor (etanercept)for treating ankylosing spondylitis:a randomized,controlled trial[J].Arthritis Rheum, 2003,48: 3230.
  • 10[11]Braun J,Brandt J,Listing J,et al.Treatment of active ankylosing spondylitis with infliximab:a randomized controlled multicenter trial[J].Lancet,2002,359:1187.

二级参考文献8

  • 1Bennett RM.Psoriatic arthritisIn,1992.
  • 2Moll JM;Wright V.Psoriatic arthritis[J],1973.
  • 3Gladman DD;Shuckett R;Russell ML.Psoriatic arthritis:an analysis of 220 patients,1987.
  • 4Kammer GM;Soter NA;Gibson DJ.Psoriatic arthritis:a clinical immunologic and HLA study of 100 patients[J],1979.
  • 5Battistone MJ;Manaster BJ;Reda DJ.The prevalence of sacroiliitis in psoriatic arthritis:new perspectives from a large,multicenter cohort.A Department of Eterans Affairs Cooperative Study[J],1999.
  • 6Vaquero CG;Moreno JR;Ros S.Termination of disease-modifying drugs in psoriatic arthritis:study of 109 courses of treatment,1996.
  • 7Wagner SA;Peter RU;Adam O.Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis[J],1993.
  • 8张江林,黄烽,刘湘源.银屑病关节炎临床特点及与HLA-B27的相关性研究[J].中华风湿病学杂志,1999,3(2):87-89. 被引量:23

共引文献23

同被引文献72

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部